艾意凯：2024印度医疗器械报销现状及未来前景报告（英文版）（19页）.pdf

1、SPECIAL REPORTCollaborating for a Robust Medical Device Reimbursement Pathway in IndiaSPECIAL REPORTContentsAbout L.E.K.ConsultingWere L.E.K.Consulting,a global strategy consultancy working with business leaders to seize competitive advantage and amplify growth.Our insights are catalysts that reshap

2、e the trajectory of our clients businesses,uncovering opportunities and empowering them to master their moments of truth.Since 1983,our worldwide practice spanning the Americas,Asia Pacific and Europe has guided leaders across all industries from global corporations to emerging entrepreneurial busin

3、esses and private equity investors.Looking for more?Visit .L.E.K.Consulting is a registered trademark of L.E.K.Consulting LLC.All other products and brands mentioned in this document are properties of their respective owners.2023 L.E.K.Consulting LLCExecutive summary.3Introduction.4Key challenges.5P

4、oints of deliberation.8Conclusion .13About the authors.15Participating experts.162 L.E.K.ConsultingSPECIAL REPORTExecutive summaryHealth technology assessments(HTAs)and evidence-driven decision-making are becoming key hallmarks of Indias social health insurance scheme,Ayushman Bharat Pradhan Mantri

5、Jan Arogya Yojana(AB-PMJAY),in its ambitious quest to expand healthcare coverage for Indias underserved populations.However,longer assessment timelines,delayed adoption by states and lack of formalized reimbursement application tracking mechanisms have emerged as key challenges within the reimbursem

6、ent process.In this document,we propose key recommendations to streamline the current reimbursement process,with the goal of improving patient access.To this end,we propose an enhanced digital-native pathway for the submission of applications,collaborative dialogue,exchange of information and appeal